| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.7M | — | -0.5% |
| Cost of Revenue | $7.5M | — | -9.8% |
| R&D Expense | $3.8M | — | -32.7% |
| SG&A Expense | $4.7M | — | -40.9% |
| Operating Income | -$5.5M | — | +50.2% |
| Pre-tax Income | -$5.9M | — | +47.2% |
| Income Tax | $0 | — | — |
| Net Income | -$5.9M | — | +47.2% |
| EPS (Basic) | -$0.04 | — | +42.9% |
| EPS (Diluted) | -$0.04 | — | +42.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.9M | -19.3% | -52.4% |
| Accounts Receivable | $5.9M | -25.8% | -52.9% |
| Inventory | $12.7M | -16.7% | -34.6% |
| Current Assets | $57.7M | -11.2% | -48.4% |
| Total Assets | $99.4M | -7.0% | -42.9% |
| Current Liabilities | $28.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.1M | — | +49.3% |
| Investing Cash Flow | -$1.4M | — | -49.2% |
| Financing Cash Flow | -$333K | — | -49.3% |
| -41.2% |
| Long-term Debt | $4.3M | -7.0% | -23.1% |
| Total Liabilities | $47.1M | -3.4% | -36.3% |
| Stockholders' Equity | $52.3M | -9.9% | -47.8% |